ERIN POPE: Open Payments
NPI 1649275769 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 36 payments from 12 companies in 2025. Trend: 2023 $187 · 2024 $327 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 6 | $174 |
| UCB, Inc. | 9 | $169 |
| ABBVIE INC. | 5 | $113 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| SK Life Science, Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $36 |
| TG Therapeutics, Inc. | 1 | $33 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $32 |
Products named: EPIDIOLEX, Briviact, QULIPTA, KESIMPTA, AUSTEDO XR, INGREZZA, VYEPTI, BRIUMVI.
Industry payments across KY — which companies pay providers there.
